1 drug(s) with this reaction
2,966 total reports
Febrile Neutropenia has been reported as an adverse reaction across 1 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 2,966 adverse event reports mention febrile neutropenia in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with febrile neutropenia, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have febrile neutropenia listed in their FDA adverse event reports, sorted by report count:
In addition to febrile neutropenia, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
1 drug(s) manufactured by Abbvie Inc have febrile neutropenia listed in their FDA adverse event reports: VENETOCLAX.
There are a combined 2,966 reports of febrile neutropenia across 1 Abbvie Inc drug(s) in the FDA adverse event database.